1. Homepage
  2. Equities
  3. Sweden
  4. Nasdaq Stockholm
  5. Biotage AB (publ)
  6. Summary
    BIOT   SE0000454746

BIOTAGE AB (PUBL)

(BIOT)
  Report
Delayed Nasdaq Stockholm  -  11:29 2022-08-09 am EDT
205.00 SEK   -0.77%
07/19Biotage AB (publ) Interim Report January - June 2022
AQ
07/19Biotage AB Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022
CI
05/25Biotage Launches New Flash Purification System
AQ
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq Stockholm
08/03/2022 08/04/2022 08/05/2022 08/08/2022 08/09/2022 Date
208.8(c) 206.8(c) 200.2(c) 206.6(c) 205(c) Last
20 911 22 342 22 568 74 282 49 162 Volume
+1.26% -0.96% -3.19% +3.20% -0.77% Change
More quotes
Estimated financial data (e)
Sales 2022 1 572 M 155 M 155 M
Net income 2022 256 M 25,2 M 25,2 M
Net cash position 2022 196 M 19,3 M 19,3 M
P/E ratio 2022 52,4x
Yield 2022 1,00%
Sales 2023 1 773 M 174 M 174 M
Net income 2023 301 M 29,6 M 29,6 M
Net cash position 2023 325 M 32,0 M 32,0 M
P/E ratio 2023 44,7x
Yield 2023 1,16%
Capitalization 13 527 M 1 331 M 1 331 M
EV / Sales 2022 8,48x
EV / Sales 2023 7,45x
Nbr of Employees 499
Free-Float 99,4%
More Financials
Company
Biotage AB is a Sweden-based company that develops and sells systems, consumables and services in the field of life sciences. Its customers include pharmaceutical and biotechnology companies, companies within the food industry and academic institutions. The Company offers systems and services within three areas: analytical chemistry, organic chemistry and industrial resins. Biotage’s offering within analytical... 
More about the company
Ratings of Biotage AB (publ)
Trading Rating : 
Investor Rating : 
ESG Refinitiv : 
B+
More Ratings
All news about BIOTAGE AB (PUBL)
07/19Biotage AB (publ) Interim Report January - June 2022
AQ
07/19Biotage AB Reports Earnings Results for the Second Quarter and Six Months Ended June 30..
CI
05/25Biotage Launches New Flash Purification System
AQ
05/20Biotage Launches New High Volume Automated Sample Preparation Workstation
AQ
04/29BIOTAGE AB (PUBL) : Ex-dividend day for final dividend
FA
04/28Resolutions at the Annual General Meeting in Biotage AB on April 28, 2022
AQ
04/28Biotage AB Appoints Torben Jørgensen Chairman of the Board
CI
04/28Biotage AB Announces Board Changes
CI
04/28Biotage AB Approves Dividend, Payable on 5 May 2022
CI
04/28Biotage AB (publ) Interim report January – March 2022
AQ
04/28Biotage AB Reports Earnings Results for the First Quarter Ended March 31, 2022
CI
04/19INVITATION TO BIOTAGE'S PRESENTATION : 00
AQ
04/07Biotage AB (publ) publishes its 2021 Annual Report
AQ
03/28NOTICE OF ANNUAL GENERAL MEETING IN BIOTAGE AB (publ)
AQ
03/14Biotage AB (publ) publishes new Financial Goals
AQ
More news
News in other languages on BIOTAGE AB (PUBL)
07/19Biotage AB (publ) annonce ses résultats pour le deuxième trimestre et le semestre clos ..
04/28Biotage AB (publ) nomme Torben Jørgensen président du conseil d'administration
04/28Biotage AB annonce des changements au sein de son conseil d'administration
04/28Biotage AB approuve un dividende, payable le 5 mai 2022
04/28Biotage AB (publ) annonce ses résultats pour le premier trimestre clos le 31 mars 2022
More news
Chart BIOTAGE AB (PUBL)
Duration : Period :
Biotage AB (publ) Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends BIOTAGE AB (PUBL)
Short TermMid-TermLong Term
TrendsNeutralNeutralNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 2
Last Close Price 205,00 SEK
Average target price 249,00 SEK
Spread / Average Target 21,5%
EPS Revisions
Managers and Directors
Tomas Blomquist President & Chief Executive Officer
Maja Nilsson Chief Financial Officer
Torben Vedel Stahl Jörgensen Chairman
Jon-Sverre Schanche Chief Scientific Officer
Magnus Nordstedt Executive Vice President-IT & Digitalization
Sector and Competitors